Bernstein Harold sold MAZE
February 2, 2026 · Form 4 insider transaction
Bernstein Harold sold 8,364 shares of Maze Therapeutics, Inc. at $45.89 per share, a transaction worth $383.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,364
Price
$45.89
Total value
$383.8K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after6,036
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.20 to $46.19 per share, inclusive.